[
    [
        {
            "time": "2023-10-05",
            "original_text": "Top Analyst Reports for Citigroup, Novo Nordisk & BP",
            "features": {
                "keywords": [
                    "Citigroup",
                    "Novo Nordisk",
                    "BP",
                    "analyst reports"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "healthcare",
                    "energy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Top Analyst Reports for Citigroup, Novo Nordisk & BP",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Can Novo Nordisk A/S's (CPH:NOVO B) ROE Continue To Surpass The Industry Average?",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "ROE",
                    "industry average"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Can Novo Nordisk A/S's (CPH:NOVO B) ROE Continue To Surpass The Industry Average?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]